Concultancy

NUVISAN offers pharmaceutical consultancy services from drug discovery to registration, provided by seasoned pharma industry professionals. Spreading from Germany to all over Europe, we have satisfied new and returning clients in various areas of drug development. We recognized that the demands of the modern healthcare industry require tailored approaches to bring compounds as fast as possible and with appropriate quality into the next phase, and that the ‘one-solution-fits-all’ paradigm is no longer relevant.

 

At present, our consultancy services comprise the following (but may not be limited to)

• Impurity profiling with safety evaluations
• Design of DMPK/ADME in vitro and in vivo studies (with unlabeled or radiolabeled test materials)
• Human PK predictions
• Drug-drug interaction assessments
• Due diligences
• Project development plan reviews with strategic directions
• Project management and DMPK representation (as external member of your project team)
• Clinical monitoring
• Regulatory affairs
• Scientific writing (study reports, IB, IMPD, IND, briefing books)
• Dossier analyses including proposals to close gaps with assessments and/or conduct of new non-clinical or clinical studies